GeneDx Holdings Corp. - Common Stock (WGS)

Historical Holders from Q1 2023 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
WGS on Nasdaq
Shares outstanding
28,736,767
Price per share
$130.06
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
30,100,794
Total reported value
$3,243,258,025
% of total 13F portfolios
0.02%
Share change
-1,454,827
Value change
-$145,765,886
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
264
Price from insider filings
$140.45
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of GeneDx Holdings Corp. - Common Stock (WGS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CMLS Holdings LLC 12% -12% $375,826,799 -$48,159,994 3,630,826 -11% Keith A. Meister 22 Aug 2025
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 4.3% -23% $133,132,271 -$42,634,981 1,235,681 -24% WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 30 Sep 2025
GOLDMAN SACHS GROUP INC 3.9% -26% $122,860,496 -$34,984,913 1,106,752 -22% THE GOLDMAN SACHS GROUP, INC. 31 Mar 2025
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 3% -43% $75,374,001 -$48,643,788 867,265 -39% Summit Partners Public Asset Management, LLC 30 Jun 2025
FMR LLC 0.6% -94% $14,194,477 -$228,627,966 163,324 -94% FMR LLC 30 Jun 2025
As of 30 Sep 2025, GeneDx Holdings Corp. - Common Stock (WGS) has 264 institutional shareholders filing 13F forms. They hold 30,100,794 shares. .

Top 25 institutional shareholders own 75% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Corvex Management LP 11% 3,058,629 0% 12% $329,536,688
Casdin Capital, LLC 10% 3,007,164 -14% 27% $323,991,849
BlackRock, Inc. 5.3% 1,529,075 +6.6% 0% $164,742,539
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 4.2% 1,220,138 -25% 0.34% $131,457,668
VANGUARD GROUP INC 4.1% 1,170,422 -0.89% 0% $126,101,267
GOLDMAN SACHS GROUP INC 4.1% 1,168,180 +11% 0.02% $125,859,714
ORACLE INVESTMENT MANAGEMENT INC 3.1% 889,954 -3.5% 67% $95,883,644
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 2.9% 823,567 +7.3% 2.9% $88,731,109
T. Rowe Price Investment Management, Inc. 2.5% 718,003 -31% 0.05% $77,358,000
FRANKLIN RESOURCES INC 2.4% 681,381 +102% 0.02% $73,411,935
Zweig-DiMenna Associates LLC 2.1% 602,300 +2.8% 5% $64,891,802
JENNISON ASSOCIATES LLC 2.1% 598,426 +50% 0.04% $64,474,418
WESTFIELD CAPITAL MANAGEMENT CO LP 1.9% 544,094 -7.7% 0.25% $58,620,688
LORD, ABBETT & CO. LLC 1.8% 525,377 +21% 0.17% $56,604,000
FMR LLC 1.8% 503,309 +208% 0% $54,226,598
Invesco Ltd. 1.7% 494,072 -11% 0.01% $53,231,317
GEODE CAPITAL MANAGEMENT, LLC 1.7% 489,397 +0.97% 0% $52,735,613
RAYMOND JAMES FINANCIAL INC 1.7% 475,543 +15% 0.02% $51,235,002
MORGAN STANLEY 1.6% 467,812 -4% 0% $50,402,119
ARK Investment Management LLC 1.6% 446,979 0.29% $48,157,485
STATE STREET CORP 1.5% 439,806 +5.7% 0% $47,384,698
Pentwater Capital Management LP 1.5% 425,000 -65% 0.41% $45,789,500
Driehaus Capital Management LLC 1.4% 410,030 +35% 0.32% $44,176,632
WELLINGTON MANAGEMENT GROUP LLP 1.4% 395,731 -2.7% 0.01% $42,636,058
ALLIANCEBERNSTEIN L.P. 1.3% 360,063 -6.9% 0.01% $38,793,188

Institutional Holders of GeneDx Holdings Corp. - Common Stock (WGS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 277,948 $36,185,802 +$32,606,977 13,005.98% 7
2025 Q3 30,100,794 $3,243,258,025 -$145,765,886 10,774% 264
2025 Q2 31,497,581 $2,907,518,951 +$295,483,780 9,231% 227
2025 Q1 28,348,693 $2,510,002,958 +$418,104,940 8,856.5% 223
2024 Q4 23,530,792 $1,808,818,954 +$346,627,584 7,686% 197
2024 Q3 18,827,893 $799,061,927 +$96,660,873 4,244% 133
2024 Q2 16,284,875 $425,689,987 +$75,857,439 2,614% 85
2024 Q1 13,907,881 $126,979,303 +$14,714,242 913% 56
2023 Q4 12,439,878 $34,209,188 -$4,757,540 275% 45
2023 Q3 13,944,728 $50,758,465 -$946,527 364% 52
2023 Q2 13,953,489 $83,162,048 -$76,091,712 596% 56
2023 Q1 26,718,966 $9,627,559 +$9,627,559 36.27% 2